_id
69104f44ccc777a4e85d538b
Ticker
CKDXF
Name
Opthea Ltd
Exchange
PINK
Address
Level 9, Melbourne, VIC, Australia, 3000
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://opthea.com
Description
Opthea Limited, a clinical-stage biopharmaceutical company, researches and develops therapeutic products based on targeting vascular endothelial growth factors (VEGF) C, D and R3 in Australia and the United States. The company's pipeline includes Sozinibercept, which is in phase 3 to treat wet age-related macular degeneration (Wet AMD), as well as in phase 2 to treat diabetic macular edema (DME). It serves the biotechnology and healthcare industries. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is headquartered in Melbourne, Australia.
Last Close
0.29
Volume
130
Current Price
0.44
Change
0
Last Updated
2026-01-02T11:27:42.625Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
601910336
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
1036
Cost Of Revenue
69935
Gross Profit
-
Operating Expenses
73228804
Operating Income
-73227768
Interest Expense
25166992
Pretax Income
-33010751
Net Income
-32003200
Eps
-0.025991032197290983
Dividends Per Share
-
Shares Outstanding
1367978173
Income Tax Expense
-1007550
EBITDA
-7843755
Operating Margin
-7068317.374517375
Total Other Income Expense Net
40217017
Cash
48607839
Short Term Investments
-
Receivables
7631881
Inventories
-
Total Current Assets
56992273
Property Plant Equipment
-
Total Assets
56992273
Payables
9769129
Short Term Debt
247833458
Long Term Debt
-
Total Liabilities
258745463
Equity
-201753189
Bs_currency_symbol
-
Depreciation
-
Change In Working Capital
-
Cash From Operations
-92256850
Capital Expenditures
545
Cash From Investing
-543
Cash From Financing
1446490
Net Change In Cash
-83205892
Cf_currency_symbol
-
PE
-
PB
-2.6853577195253155
ROE
15.862549761233266
ROA
-56.153577170013904
FCF
-92257395
Fcf Percent
-89051.53957528957
Piotroski FScore
0
Health Score
26
Deep Value Investing Score
1
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
6.3
Garp Investing Score
2
Growth Investing Score
1.5
Momentum Investing Score
5.5
Net Net Investing Score
0.5
Quality Investing Score
2
Value Investing Score
2.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
1036
Quarters > 0 > income Statement > cost Of Revenue
69935
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
73228804
Quarters > 0 > income Statement > operating Income
-73227768
Quarters > 0 > income Statement > interest Expense
25166992
Quarters > 0 > income Statement > pretax Income
-33010751
Quarters > 0 > income Statement > net Income
-32003200
Quarters > 0 > income Statement > eps
-0.025991032197290983
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1231317008
Quarters > 0 > income Statement > income Tax Expense
-1007550
Quarters > 0 > income Statement > EBITDA
-7843755
Quarters > 0 > income Statement > operating Margin
-7068317.374517375
Quarters > 0 > income Statement > total Other Income Expense Net
40217017
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
48607839
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
7631881
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
56992273
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
56992273
Quarters > 0 > balance Sheet > payables
9769129
Quarters > 0 > balance Sheet > short Term Debt
247833458
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
258745463
Quarters > 0 > balance Sheet > equity
-201753189
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-32003200
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-92256850
Quarters > 0 > cash Flow > capital Expenditures
545
Quarters > 0 > cash Flow > cash From Investing
-543
Quarters > 0 > cash Flow > cash From Financing
1446490
Quarters > 0 > cash Flow > net Change In Cash
-83205892
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.025991032197290983
Quarters > 0 > ratios > PB
-2.6853577195253155
Quarters > 0 > ratios > ROE
15.862549761233266
Quarters > 0 > ratios > ROA
-56.153577170013904
Quarters > 0 > ratios > FCF
-92257395
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-89051.53957528957
Quarters > 0 > health Score
26
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
7175.5
Quarters > 1 > income Statement > cost Of Revenue
13673
Quarters > 1 > income Statement > gross Profit
7175.5
Quarters > 1 > income Statement > operating Expenses
4448762.5
Quarters > 1 > income Statement > operating Income
-4124354.91
Quarters > 1 > income Statement > interest Expense
35934
Quarters > 1 > income Statement > pretax Income
-3739753.77
Quarters > 1 > income Statement > net Income
-2475209.8
Quarters > 1 > income Statement > eps
-0.04900532473452204
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
50508997
Quarters > 1 > income Statement > income Tax Expense
-1229132.98
Quarters > 1 > income Statement > EBITDA
-4459447.98
Quarters > 1 > income Statement > operating Margin
-57478.29294125845
Quarters > 1 > income Statement > total Other Income Expense Net
209816
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
-
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
-
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-
Quarters > 1 > cash Flow > depreciation
14623.5
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
-
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.04900532473452204
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
22462
Quarters > 2 > income Statement > cost Of Revenue
22462
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
79800529
Quarters > 2 > income Statement > operating Income
-79778066
Quarters > 2 > income Statement > interest Expense
20757141
Quarters > 2 > income Statement > pretax Income
-129057792
Quarters > 2 > income Statement > net Income
-123465587
Quarters > 2 > income Statement > eps
-0.19345819761069663
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
638202922
Quarters > 2 > income Statement > income Tax Expense
-5592204
Quarters > 2 > income Statement > EBITDA
-108300651
Quarters > 2 > income Statement > operating Margin
-355169.0232392485
Quarters > 2 > income Statement > total Other Income Expense Net
-49279726
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
131813731
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
7977810
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
144012266
Quarters > 2 > balance Sheet > property Plant Equipment
43965
Quarters > 2 > balance Sheet > total Assets
145656990
Quarters > 2 > balance Sheet > payables
30008717
Quarters > 2 > balance Sheet > short Term Debt
37970
Quarters > 2 > balance Sheet > long Term Debt
157209000
Quarters > 2 > balance Sheet > total Liabilities
314231201
Quarters > 2 > balance Sheet > equity
-168574210
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-31381000
Quarters > 2 > cash Flow > capital Expenditures
2000
Quarters > 2 > cash Flow > cash From Investing
-2000
Quarters > 2 > cash Flow > cash From Financing
8000
Quarters > 2 > cash Flow > net Change In Cash
-35597000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.19345819761069663
Quarters > 2 > ratios > PB
-1.6657903108666505
Quarters > 2 > ratios > ROE
73.24108889491458
Quarters > 2 > ratios > ROA
-84.7646151413674
Quarters > 2 > ratios > FCF
-31383000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1397.1596474045054
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-06-30
Quarters > 3 > income Statement > revenue
64687
Quarters > 3 > income Statement > cost Of Revenue
52547
Quarters > 3 > income Statement > gross Profit
12140
Quarters > 3 > income Statement > operating Expenses
99373063
Quarters > 3 > income Statement > operating Income
-99360923
Quarters > 3 > income Statement > interest Expense
20017438
Quarters > 3 > income Statement > pretax Income
-130079301
Quarters > 3 > income Statement > net Income
-125649018
Quarters > 3 > income Statement > eps
-0.18514361594228396
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
678657038
Quarters > 3 > income Statement > income Tax Expense
-4430282
Quarters > 3 > income Statement > EBITDA
-110009312
Quarters > 3 > income Statement > operating Margin
-153602.614126486
Quarters > 3 > income Statement > total Other Income Expense Net
-30718378
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
172471346
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
11824439
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
188192564
Quarters > 3 > balance Sheet > property Plant Equipment
131951
Quarters > 3 > balance Sheet > total Assets
188791216
Quarters > 3 > balance Sheet > payables
37988509
Quarters > 3 > balance Sheet > short Term Debt
93033
Quarters > 3 > balance Sheet > long Term Debt
141554653
Quarters > 3 > balance Sheet > total Liabilities
264601293
Quarters > 3 > balance Sheet > equity
-75810077
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-125649018
Quarters > 3 > cash Flow > depreciation
52547
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-92219886
Quarters > 3 > cash Flow > capital Expenditures
29567
Quarters > 3 > cash Flow > cash From Investing
-29570
Quarters > 3 > cash Flow > cash From Financing
105475527
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.18514361594228396
Quarters > 3 > ratios > PB
-3.9389103472352365
Quarters > 3 > ratios > ROE
165.74184194536565
Quarters > 3 > ratios > ROA
-66.55448312807096
Quarters > 3 > ratios > FCF
-92249453
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-1426.0895233972824
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2025-06-30
Annuals > 0 > income Statement > revenue
25000
Annuals > 0 > income Statement > cost Of Revenue
92397
Annuals > 0 > income Statement > gross Profit
25000
Annuals > 0 > income Statement > operating Expenses
155787000
Annuals > 0 > income Statement > operating Income
-155762000
Annuals > 0 > income Statement > interest Expense
46457000
Annuals > 0 > income Statement > pretax Income
-169738000
Annuals > 0 > income Statement > net Income
-162791000
Annuals > 0 > income Statement > eps
-0.13292345215022278
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1224697353
Annuals > 0 > income Statement > income Tax Expense
-6947000
Annuals > 0 > income Statement > EBITDA
-123190000
Annuals > 0 > income Statement > operating Margin
-623048
Annuals > 0 > income Statement > total Other Income Expense Net
-13976000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
48443000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
7606000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
56799000
Annuals > 0 > balance Sheet > property Plant Equipment
0
Annuals > 0 > balance Sheet > total Assets
56799000
Annuals > 0 > balance Sheet > payables
9736000
Annuals > 0 > balance Sheet > short Term Debt
247833458
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
257868000
Annuals > 0 > balance Sheet > equity
-201069000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-162791000
Annuals > 0 > cash Flow > depreciation
91000
Annuals > 0 > cash Flow > change In Working Capital
-25164735
Annuals > 0 > cash Flow > cash From Operations
-158644000
Annuals > 0 > cash Flow > capital Expenditures
13000
Annuals > 0 > cash Flow > cash From Investing
-13000
Annuals > 0 > cash Flow > cash From Financing
34767000
Annuals > 0 > cash Flow > net Change In Cash
-124028000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.13292345215022278
Annuals > 0 > ratios > PB
-2.680009525685213
Annuals > 0 > ratios > ROE
80.96275407944536
Annuals > 0 > ratios > ROA
-286.6089191711122
Annuals > 0 > ratios > FCF
-158657000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-6346.28
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2024-06-30
Annuals > 1 > income Statement > revenue
124666
Annuals > 1 > income Statement > cost Of Revenue
102652
Annuals > 1 > income Statement > gross Profit
22014
Annuals > 1 > income Statement > operating Expenses
191967399
Annuals > 1 > income Statement > operating Income
-191842733
Annuals > 1 > income Statement > interest Expense
30263042
Annuals > 1 > income Statement > pretax Income
-229654301
Annuals > 1 > income Statement > net Income
-220242105
Annuals > 1 > income Statement > eps
-0.3450972996328588
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
638202922
Annuals > 1 > income Statement > income Tax Expense
-9412196
Annuals > 1 > income Statement > EBITDA
-199288234
Annuals > 1 > income Statement > operating Margin
-153885.36810357275
Annuals > 1 > income Statement > total Other Income Expense Net
-37811568
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
172471346
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
11824439
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
188192564
Annuals > 1 > balance Sheet > property Plant Equipment
131951
Annuals > 1 > balance Sheet > total Assets
188791216
Annuals > 1 > balance Sheet > payables
37988593
Annuals > 1 > balance Sheet > short Term Debt
93033
Annuals > 1 > balance Sheet > long Term Debt
141554653
Annuals > 1 > balance Sheet > total Liabilities
264601293
Annuals > 1 > balance Sheet > equity
-75810077
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-220242105
Annuals > 1 > cash Flow > depreciation
104803
Annuals > 1 > cash Flow > change In Working Capital
17304508
Annuals > 1 > cash Flow > cash From Operations
-161015354
Annuals > 1 > cash Flow > capital Expenditures
33489
Annuals > 1 > cash Flow > cash From Investing
-33489
Annuals > 1 > cash Flow > cash From Financing
243728835
Annuals > 1 > cash Flow > net Change In Cash
83282633
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.3450972996328588
Annuals > 1 > ratios > PB
-3.704115558146709
Annuals > 1 > ratios > ROE
290.5182446919293
Annuals > 1 > ratios > ROA
-116.65908492267987
Annuals > 1 > ratios > FCF
-161048843
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-1291.8425472863491
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2023-06-30
Annuals > 2 > income Statement > revenue
161163
Annuals > 2 > income Statement > cost Of Revenue
250472
Annuals > 2 > income Statement > gross Profit
-89309
Annuals > 2 > income Statement > operating Expenses
223459931
Annuals > 2 > income Statement > operating Income
-223449260
Annuals > 2 > income Statement > interest Expense
13462160
Annuals > 2 > income Statement > pretax Income
-220691160
Annuals > 2 > income Statement > net Income
-211880680
Annuals > 2 > income Statement > eps
-0.4512351159734523
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
469557161
Annuals > 2 > income Statement > income Tax Expense
-8810479
Annuals > 2 > income Statement > EBITDA
-223298770
Annuals > 2 > income Statement > operating Margin
-138647.9899232454
Annuals > 2 > income Statement > total Other Income Expense Net
-70665366
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
133987400
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
6562914
Annuals > 2 > balance Sheet > inventories
1
Annuals > 2 > balance Sheet > total Current Assets
147804849
Annuals > 2 > balance Sheet > property Plant Equipment
302690
Annuals > 2 > balance Sheet > total Assets
148187965
Annuals > 2 > balance Sheet > payables
17842981
Annuals > 2 > balance Sheet > short Term Debt
97485
Annuals > 2 > balance Sheet > long Term Debt
85660000
Annuals > 2 > balance Sheet > total Liabilities
156981141
Annuals > 2 > balance Sheet > equity
-8793176
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-211880680
Annuals > 2 > cash Flow > depreciation
150488
Annuals > 2 > cash Flow > change In Working Capital
20745951
Annuals > 2 > cash Flow > cash From Operations
-179303893
Annuals > 2 > cash Flow > capital Expenditures
32638
Annuals > 2 > cash Flow > cash From Investing
-32638
Annuals > 2 > cash Flow > cash From Financing
248696415
Annuals > 2 > cash Flow > net Change In Cash
69083317
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.4512351159734523
Annuals > 2 > ratios > PB
-23.49607819063328
Annuals > 2 > ratios > ROE
2409.603538016298
Annuals > 2 > ratios > ROA
-142.9810308819613
Annuals > 2 > ratios > FCF
-179336531
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1112.7649088190217
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2022-06-30
Annuals > 3 > income Statement > revenue
125047
Annuals > 3 > income Statement > cost Of Revenue
232469
Annuals > 3 > income Statement > gross Profit
-107422
Annuals > 3 > income Statement > operating Expenses
133287045
Annuals > 3 > income Statement > operating Income
-133270080
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-136676594
Annuals > 3 > income Statement > net Income
-127990214
Annuals > 3 > income Statement > eps
-0.34319164592006157
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
372940937
Annuals > 3 > income Statement > income Tax Expense
-8686380
Annuals > 3 > income Statement > EBITDA
-99008573
Annuals > 3 > income Statement > operating Margin
-106575.99142722336
Annuals > 3 > income Statement > total Other Income Expense Net
-3406514
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
64904083
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
6579552
Annuals > 3 > balance Sheet > inventories
1
Annuals > 3 > balance Sheet > total Current Assets
87120543
Annuals > 3 > balance Sheet > property Plant Equipment
40837
Annuals > 3 > balance Sheet > total Assets
87321775
Annuals > 3 > balance Sheet > payables
11402164
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
17552061
Annuals > 3 > balance Sheet > equity
69769714
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-127990214
Annuals > 3 > cash Flow > depreciation
108084
Annuals > 3 > cash Flow > change In Working Capital
20221828
Annuals > 3 > cash Flow > cash From Operations
-98367101
Annuals > 3 > cash Flow > capital Expenditures
23317
Annuals > 3 > cash Flow > cash From Investing
-23317
Annuals > 3 > cash Flow > cash From Financing
236623
Annuals > 3 > cash Flow > net Change In Cash
-92529386
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.34319164592006157
Annuals > 3 > ratios > PB
2.351937579678197
Annuals > 3 > ratios > ROE
-183.446665697956
Annuals > 3 > ratios > ROA
-146.57307870803132
Annuals > 3 > ratios > FCF
-98390418
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-786.8274968611802
Annuals > 3 > health Score
35
Valuation > metrics > PE
-0.025991032197290983
Valuation > metrics > PB
-2.6853577195253155
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
15.862549761233266
Profitability > metrics > ROA
-56.153577170013904
Profitability > metrics > Net Margin
-30891.11969111969
Profitability > final Score
32
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-2.909675021949385
Risk > final Score
18
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.2212410739493078
Liquidity > metrics > Quick Ratio
0.2212410739493078
Liquidity > final Score
21
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
35
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
-429
Prev Risks > 1
15
Prev Risks > 2
10
Prev Liquidities > 0
50
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:36:31.760Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Opthea Limited, a clinical-stage biopharmaceutical company, researches and develops therapeutic products based on targeting vascular endothelial growth factors (VEGF) C, D and R3 in Australia and the United States. The company's pipeline includes Sozinibercept, which is in phase 3 to treat wet age-related macular degeneration (Wet AMD), as well as in phase 2 to treat diabetic macular edema (DME). It serves the biotechnology and healthcare industries. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is headquartered in Melbourne, Australia.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Medium
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Opthea Ltd
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.